(NASDAQ: KOD) Kodiak Sciences's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 49.64%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.62%.
Kodiak Sciences's revenue in 2025 is $0.On average, 1 Wall Street analysts forecast KOD's revenue for 2027 to be $2,350,177,747, with the lowest KOD revenue forecast at $2,350,177,747, and the highest KOD revenue forecast at $2,350,177,747. On average, 1 Wall Street analysts forecast KOD's revenue for 2028 to be $7,268,921,903, with the lowest KOD revenue forecast at $7,268,921,903, and the highest KOD revenue forecast at $7,268,921,903.
In 2029, KOD is forecast to generate $12,757,055,293 in revenue, with the lowest revenue forecast at $12,757,055,293 and the highest revenue forecast at $12,757,055,293.